Tag: DoH

Abu Dhabi Opens Strategic Life Sciences Corridor to California Through Biocom Partnership

ABU DHABI, UAE, June 24 -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Biocom California, one of the world's largest life sciences associations representing more than 1,800 biotechnology, pharmaceutical and medical technology organisations, have announced a strategic partnership that will create a formal gateway between Abu Dhabi and California's life sciences ecosystems. The collaboration will strengthen connectivity between innovators, researchers, investors and entrepreneurs across both markets, creating new opportunities to accelerate the development, validation and scaling of next-generation health solutions. Both parties will exchange expertise on life sciences ecosystem and cluster development, including industry best practices, sector policy insights and lessons learned, helping strengthen innovation environments and accelerate the growth of high-value life sciences activities in both regions. The partnership connects California's globally renowned life sciences community with Abu Dhabi's Health, Endurance, Longevity and Medicine (HELM) Cluster, creating opportunities for companies to build, test and scale innovations across both markets. Through Biocom California, US-based biotechnology, pharmaceutical and medical technology leaders will be provided access to Abu Dhabi's intelligent life sciences ecosystem and living lab model, where discovery, validation and real-world implementation happen within a single environment. H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of DoH, said: "The most successful life sciences ecosystems are those that can connect talent, research, investment and implementation across borders. Through this partnership with Biocom, we are creating a direct bridge between Abu Dhabi's intelligent life sciences ecosystem and one of the world's leading centres of life sciences innovation. For innovators, researchers, and investors, this creates new opportunities to access Abu Dhabi's living lab for intelligent life sciences, where scientific discoveries can be translated into real-world impact faster and at scale." Joe Panetta, President Emeritus of Biocom said: " Biocom is honored to be partnering with the DoH under this important MOU. Abu Dhabi life science ecosystem is strategically focused and well supported for the creation of promising new and innovative life science therapies. Biocom reaches out actively to develop a network of partnerships in established and growing life science ecosystems around the world. Under this MOU we look forward to cooperating jointly in events, providing opportunities to find partners for companies in both California and Abu Dhabi and connecting Abu Dhabi to our other partners." -- PRNewswire -- Source: The Department of Health - Abu Dhabi

ABU DHABI, UAE, June 24 — The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Biocom California, one of the world’s largest life sciences associations representing more than 1,800 biotechnology, pharmaceutical and medical technology organisations, have announced a strategic partnership that will create a formal gateway between Abu […]

DoH and Sanofi Partner to Advance Vaccine Innovation

ABU DHABI, UAE, June 23 -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Sanofi, a worldwide biopharma and vaccines leader, have signed an Memorandum of Understanding and intend to into an agreement to advance their partnership in vaccine innovation and to jointly explore the development of a Vaccine Innovation Centre in Abu Dhabi. The collaboration would strengthen capabilities across AI-enabled vaccine discovery, mRNA research, clinical development and manufacturing, and support regional and global preparedness for future public health challenges.     Operating within Abu Dhabi's Health, Endurance, Longevity, and Medicine (HELM) Cluster, the collaboration intends to bring together scientific research, clinical infrastructure, academic expertise, enabling regulation and advanced manufacturing within a single ecosystem. H.E. Dr. Noura Al Ghaithi, Undersecretary of the DoH, said: "Through our partnership with Sanofi, we are bringing together AI, scientific research, clinical expertise, advanced manufacturing and enabling regulation within a single ecosystem designed to accelerate the journey from discovery to impact. This partnership reflects Abu Dhabi's commitment to creating an environment where innovators can build, test and scale solutions that improve lives, strengthen preparedness and advance health outcomes for communities around the world." Baptiste de Clarens, General Manager Vaccines, Greater Gulf at Sanofi, said: "We are proud to deepen our collaboration with the DoH. Vaccine innovation today is being reshaped by artificial intelligence, by advances in mRNA science, and by new models that connect discovery, development and manufacturing. We look forward to exploring how these capabilities can be brought together to accelerate the journey from discovery to the patients." The planned Vaccine Innovation Centre is expected to strengthen Abu Dhabi's contribution to global health security while supporting the development of local scientific talent, advanced manufacturing capabilities and next-generation vaccine innovation. Through the advancement of vaccine research, development and manufacturing capabilities in the region, the centre will help expand access to advanced vaccines and strengthen preparedness for future public health challenges. The announcement forms part of Abu Dhabi's participation at BIO International Convention 2026, where the emirate is showcasing its intelligent life sciences ecosystem and partnerships across genomics, gene editing, AI-enabled health innovation, advanced therapeutics and rare disease. A key enabler of the emirates intelligent life sciences ecosystem is Abu Dhabi's Health, Endurance, Longevity and Medicine (HELM) Cluster, which connects research, investment, commercialisation and healthcare implementation within a single ecosystem. -- PRNewswire -- Source: The Department of Health - Abu Dhabi   

ABU DHABI, UAE, June 23 — The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Sanofi, a worldwide biopharma and vaccines leader, have signed an Memorandum of Understanding and intend to into an agreement to advance their partnership in vaccine innovation and to jointly explore the development of […]